ENOXAPARIN 300 MG/3 ML VIAL
For 3 mL
Pharmacies pay
$29.62 filed
3 × $9.87241 per ML
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$36.75 filed
3 × $12.25145 per ML, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
1.2× estimated
Medicare paid 1.2× what pharmacies pay.
Part D averages every strength and form sold under “Enoxaparin Sodium” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$39.06 estimated
$29.62 + $4.44 (15%) + $5.00 fee per fill = $39.06
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ENOXAPARIN 300 MG/3 ML VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as enoxaparin sodium.
FDA gives its dosage form as injection and its route as “intravenous; subcutaneous” and “subcutaneous”.
FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Amphastar Pharmaceuticals, Inc., Sanofi-Aventis U.S. LLC and Fresenius Kabi USA, LLC.
FDA’s Established Pharmacologic Class for it is Low Molecular Weight Heparin.
The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $29.62 for 3 mL (3 × $9.87241 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.
What NADAC measures · NADAC explanation codes
All 6 NDCs
- 00548-5608-00 · Amphastar Pharmaceuticals, Inc. · $9.87241 per ML · eff. 2026-09-23 filed
- 00955-1016-01 · Sanofi-Aventis U.S. LLC · $9.87241 per ML · eff. 2026-09-23 filed
- 63323-0539-03 · Fresenius Kabi USA, LLC · $9.87241 per ML · eff. 2026-09-23 filed
- 68001-0641-41 · BluePoint Laboratories · $9.87241 per ML · eff. 2026-09-23 filed
- 71288-0426-03 · Meitheal Pharmaceuticals Inc. · $9.87241 per ML · eff. 2026-09-23 filed
- 71288-0426-91 · Meitheal Pharmaceuticals Inc. · $9.87241 per ML · eff. 2026-09-23 filed
Other strengths, forms and brands
8 other products in the NADAC file share the FDA nonproprietary name enoxaparin sodium with ENOXAPARIN 300 MG/3 ML VIAL.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ENOXAPARIN 30 MG/0.3 ML SYR | $9.12683 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 40 MG/0.4 ML SYR | $7.7791 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 60 MG/0.6 ML SYR | $7.45223 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 80 MG/0.8 ML SYR | $6.68676 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 100 MG/ML SYRINGE | $6.45169 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 120 MG/0.8 ML SYR | $10.41734 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 150 MG/ML SYRINGE | $8.90376 per ML filed | $12.25145 per ML filed |
| ENOXAPARIN 300 MG/3 ML VIAL this page | $9.87241 per ML filed | $12.25145 per ML filed |
| LOVENOX 40 MG/0.4 ML SYRINGE | $6.775 per ML filed | $24.7979 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2025-11-19, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 6 NDCs’ NADAC prices is $9.87241 per ML filed.
Of the 8 other products in FDA’s Low Molecular Weight Heparin class priced per ML, 1 has a higher middle NADAC price and 7 a lower one. The one in the middle is ENOXAPARIN 60 MG/0.6 ML SYR, at $7.45223 per ML filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $36.75 for 3 mL, at an average of $12.25145 per ML in 2024 (2024-01-01 to 2024-12-31) for “Enoxaparin Sodium”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 532,949 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 3 mL? Is it lower than what I would pay through my insurance?
- How much is in the package I am getting? This page uses 3 mL; your package may hold a different amount.
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ENOXAPARIN 300 MG/3 ML VIAL labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Enoxaparin Sodium / Enoxaparin Sodium: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
- Why does this page start at 3 mL?
- NADAC prices this product per ML. The FDA NDC Directory’s package description gives 3 mL in one package for all 6 NDCs of this product (“1 VIAL in 1 CARTON (0548-5608-00) / 3 mL in 1 VIAL”), so the card starts at one package: 3 ML. Change it to match your prescription.